- Home
- NEGG vs RCEL Comparison
NEGG vs RCEL Comparison
Compare NEGG & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- RCEL
- Stock Information
- Founded
- NEGG 2001
- RCEL N/A
- Country
- NEGG United States
- RCEL United States
- Employees
- NEGG N/A
- RCEL N/A
- Industry
- NEGG Other Specialty Stores
- RCEL Medical/Dental Instruments
- Sector
- NEGG Consumer Discretionary
- RCEL Health Care
- Exchange
- NEGG Nasdaq
- RCEL Nasdaq
- Market Cap
- NEGG 122.3M
- RCEL 161.5M
- IPO Year
- NEGG 2010
- RCEL N/A
- Fundamental
- Price
- NEGG $16.83
- RCEL $5.42
- Analyst Decision
- NEGG
- RCEL Strong Buy
- Analyst Count
- NEGG 0
- RCEL 4
- Target Price
- NEGG N/A
- RCEL $16.50
- AVG Volume (30 Days)
- NEGG 1.3M
- RCEL 316.4K
- Earning Date
- NEGG 08-28-2025
- RCEL 08-07-2025
- Dividend Yield
- NEGG N/A
- RCEL N/A
- EPS Growth
- NEGG N/A
- RCEL N/A
- EPS
- NEGG N/A
- RCEL N/A
- Revenue
- NEGG $1,235,576,000.00
- RCEL $71,661,000.00
- Revenue This Year
- NEGG N/A
- RCEL $57.16
- Revenue Next Year
- NEGG N/A
- RCEL $36.69
- P/E Ratio
- NEGG N/A
- RCEL N/A
- Revenue Growth
- NEGG N/A
- RCEL 41.35
- 52 Week Low
- NEGG $3.32
- RCEL $4.71
- 52 Week High
- NEGG $26.40
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- NEGG 69.10
- RCEL 43.61
- Support Level
- NEGG $15.00
- RCEL $5.11
- Resistance Level
- NEGG $17.74
- RCEL $5.55
- Average True Range (ATR)
- NEGG 2.00
- RCEL 0.31
- MACD
- NEGG 0.44
- RCEL 0.10
- Stochastic Oscillator
- NEGG 90.44
- RCEL 69.61
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.